← iAvoxel
Transparent roadmap · Updated April 2026

Product Roadmap

What's live, what's next, and what we need partners for. No vaporware — every item below ships with a timeline and a responsible person.

Q2 2026
Pilots

Phase 1 — Pilot openings + compliance closure

IACardio Hospital pilot openings — Oriental region, open to candidate hospitals
iAutisme Pilot signed with a research center in Marrakech + offline field mode — DONE
Holter 4G ABPM available on order for partnering hospitals
Compliance CNDP authorization under review
Compliance Moroccan sovereign-cloud infrastructure alignment
IACardio 4 production languages (FR/EN/AR/ⵜⴰⵎⴰⵣⵉⵖⵜ) — DONE
IACardio Intelligent clinical safety co-pilots integrated into the platform — DONE
iAutisme 4 production languages + 7 sub-Saharan in localization — DONE
Q3 2026
Certify

Phase 2 — Compliance & certification

Compliance ISO 13485 QMS gap closure
Compliance IEC 62304 Class B software lifecycle
Compliance ISO 27001 information security
Compliance CE marking Class IIa kickoff
Compliance External DPO migration
IACardio First clinical validation studies
Q4 2026
Scale

Phase 3 — African expansion

IACardio Open to candidate African partners (priority focus: Senegal, Côte d'Ivoire, Mauritania)
Compliance Malabo Convention data residency per country
iAutisme 7 sub-Saharan languages live
Holter Custom 72h variant certification extension
IACardio Native mobile app iOS + Android
iAutisme Physical NFC PVC card manufacturing
H1 2027
AI

Phase 4 — AI co-pilots & deep hardware

IACardio ECG AI analysis (human-in-the-loop)
IACardio EchoBox HDMI echocardiography AI (<5s)
iAutisme Wearable watch for biometric monitoring
IACardio Full FHIR R4 + DHIS2 bidirectional sync
iAutisme VR preparation environments for children
Compliance FDA Class I/II + CE MDR filing